Methenamine, Benzoic acid, Phenyl salicylate, Methylthioninium chloride, Hyoscyamine
Uribel Tabs
Contenu en anglais
Indications
Uribel Tabs are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Contre-indications
CONTRADICTIONS Hypersensitivity to any of the ingredients is possible. Risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
Mises en garde et précautions d’emploi
Do not exceed recommended dosage. If rapid pulse, dizziness or blurring of vision occurs, discontinue use immediately.
Conditionnements
| Conditionnement | Code | Statut |
|---|---|---|
| LABEL-URIBEL TABS |
Documents
Les textes officiels, sur le site de l’autorité.



